Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Dec 19, 2011
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
Design: Parallel group randomized control trial Method: All adult current smokers attending respirology clinic at the Ottawa General Hospital will be approached to participate. Concealed random allocation will be done if the subject is willing and signed the written informed consent. Experimental arm will receive counseling on site enrollment in the Ottawa Model of Smoking Cessation which includes IVR automated telephone follow-up and will receive a SmartCard worth $110 towards purchase of smoking cessation aids. Usual care arm will receive current usual care in our clinic i.e. strong physi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult \>18 years of age attending Respirology Clinic at the Ottawa General hospital
- • Current smokers (anyone who had smoked any form of tobacco in the 6 months prior to the clinic visit)
- • Willing to set quit dates in next 30 days
- Exclusion Criteria:
- • Subjects with less than 2 year life expectancy (end stage cancer, end stage lung or heart disease etc) and/or receiving palliative care
- • Not willing to sign consent
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Smita Pakhale, MD, FRCPC
Principal Investigator
OHRI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials